Correction to: No effects of COVID19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARSCoV2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects.
Acta Diabetol
; 60(10): 1309, 2023 Oct.
Article
em En
| MEDLINE
| ID: mdl-37474814
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article